EmmanuelleMClerisme-BeatyMD
Pulmonology • Sandy Hook, CTCritical Care Medicine, Pleural Disease
Physician
Are you Dr. Clerisme-Beaty?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
12 Night Hawk Ln
Sandy Hook, CT 06482Phone+1 203-417-0714
Summary
- Dr. Emmanuelle Clerisme-Beaty, MD is a pulmonologist in Sandy Hook, Connecticut. She is currently licensed to practice medicine in Connecticut and Maryland.
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2009
Yale-New Haven Medical CenterResidency, Internal Medicine, 2002 - 2005
Yale School of MedicineClass of 2002
Certifications & Licensure
CT State Medical License 2004 - 2025
MD State Medical License 2007 - 2012
Clinical Trials
- Bariatric and Obstructive Lung Disease Study II Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- 137 citationsDesign of the PF-ILD trial: A double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung diseaseKevin R. Flaherty, Kevin K. Brown, Athol U. Wells, Emmanuelle Clerisme-Beaty, Harold R. Collard
BMJ Open Respiratory Research. 2017-09-01 - 25 citationsThe Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma.Emmanuelle M. Clerisme-Beaty, Susan J. Bartlett, W. Gerald Teague, John J. Lima, Charles G. Irvin
The Journal of Allergy and Clinical Immunology. 2011-02-01 - 28 citationsA retrospective analysis to identify predictors of COPD-related rehospitalizationMelissa H. Roberts, Emmanuelle Clerisme-Beaty, Chris M. Kozma, Andrew Paris, Terra Slaton
BMC Pulmonary Medicine. 2016-04-30
Press Mentions
Newly Published Trial Results Showed Spesolimab Significantly Improved Signs and Symptoms of Flare in Rare, Life-Threatening Skin Disease, Generalized Pustular PsoriasisDecember 23rd, 2021- Newly Published Trial Results Showed Spesolimab Significantly Improved Signs and Symptoms of Flare in Rare, Life-Threatening Skin Disease, Generalized Pustular PsoriasisDecember 22nd, 2021
